DALBAVANCIN HYDROCHLORIDE

dalbavancin hydrochloride · Fresenius Kabi USA, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DALBAVANCIN HYDROCHLORIDE, covering 2025-11-10 to 2026-02-26. Get the full timeline:

Most recent: FDA Approved: DALBAVANCIN — Original Application (Long Grove Pharmaceuticals, LLC)